Corporate GovernanceSep 8, 2026, 12:41 PM
Quantum Biopharma Files Amendment to Form 6-K
AI Summary
Quantum Biopharma Ltd. has filed an amendment to its Form 6-K report, originally submitted on March 30, 2026. This amendment, filed on September 8, 2026, serves solely to incorporate Exhibit 99.1 into the company's Registration Statement on Form F-3. No other changes were made to the original report. The filing was executed by CFO Donal Carroll.
Key Highlights
- Quantum Biopharma Ltd. filed an amendment (Form 6-K/A) on September 8, 2026.
- This amendment incorporates Exhibit 99.1 from the original filing dated March 30, 2026.
- The incorporated exhibit is part of the Registrant's Registration Statement on Form F-3 (File No. 333-276264).
- The filing was signed by Donal Carroll, Chief Financial Officer.
Price Impact
More from QNTM